World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 92 11423 10738 5857 5417 525 27012

Andrew F. Shorr publications per year

The chart shows the history of publications by Andrew F. Shorr between 1986 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Andrew F. Shorr published across 41 years, from 1986 to 2026, averaging 13.4 papers a year. Output peaked at 47 publications in 2008. 13 of the 548 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1986 to 2026. Vertical axis: number of publications, 0 to 47. Peak 47 publications in 2008. 1986: 1 publication 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 1 publication 1993: 0 publications 1994: 4 publications 1995: 0 publications 1996: 3 publications 1997: 2 publications 1998: 1 publication 1999: 4 publications 2000: 3 publications 2001: 4 publications 2002: 11 publications 2003: 17 publications 2004: 27 publications 2005: 32 publications 2006: 26 publications 2007: 25 publications 2008: 47 publications 2009: 40 publications 2010: 33 publications 2011: 31 publications 2012: 47 publications 2013: 23 publications 2014: 19 publications 2015: 16 publications 2016: 14 publications 2017: 17 publications 2018: 4 publications 2019: 17 publications 2020: 15 publications 2021: 18 publications 2022: 13 publications 2023: 14 publications 2024: 6 publications 2025: 12 publications 2026: 1 publication
1986 2026

548 publications in total across all disciplines

View publications per year as a table
Andrew F. Shorr: publications per year, 1986 to 2026
Year Publications
1986 1
1987 0
1988 0
1989 0
1990 0
1991 0
1992 1
1993 0
1994 4
1995 0
1996 3
1997 2
1998 1
1999 4
2000 3
2001 4
2002 11
2003 17
2004 27
2005 32
2006 26
2007 25
2008 47
2009 40
2010 33
2011 31
2012 47
2013 23
2014 19
2015 16
2016 14
2017 17
2018 4
2019 17
2020 15
2021 18
2022 13
2023 14
2024 6
2025 12
2026 1
Total 548
Download as CSV

Andrew F. Shorr publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andrew F. Shorr sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 521–540 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 525 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610 525
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Andrew F. Shorr D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew F. Shorr sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 92–93 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839 92
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Andrew F. Shorr is affiliated with George Washington University in the United States. Their research primarily focuses on medicine with extensive contributions in epidemiology, critical care and intensive care medicine, applied microbiology and biotechnology, pharmacology, and molecular medicine. Their work covers a broad spectrum of topics related to infectious diseases and critical care.

The scientist has published extensively on key subjects including:

  • Pneumonia and Respiratory Infections
  • Nosocomial Infections in ICU
  • Antibiotic Use and Resistance
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Resistance in Bacteria
  • Bacterial Identification and Susceptibility Testing
  • Sepsis Diagnosis and Treatment

Several frequent co-authors have collaborated with Andrew F. Shorr, reflecting ongoing research partnerships. These co-authors include Marya D. Zilberberg, Brian H. Nathanson, Kate Sulham, Marin H. Kollef, and Laura Puzniak.

Andrew F. Shorr's publication record features articles in various scientific journals. The most common venues include Open Forum Infectious Diseases, Antibiotics, CHEST Journal, Critical Care Medicine, and Critical Care. This demonstrates the scientist's focus on critical care and infectious disease disciplines.

Among recent papers authored or co-authored by Andrew F. Shorr are:

  • "Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial", 2020, The Lancet Infectious Diseases
  • "Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)", 2023, The Lancet Infectious Diseases
  • "Nosocomial Infection", 2021, Critical Care Medicine
  • "Timing of antibiotic therapy in the ICU", 2021, Critical Care
  • "Characteristics, Hospital Course, and Outcomes of Patients Requiring Prolonged Acute Versus Short-Term Mechanical Ventilation in the United States, 2014-2018", 2020, Critical Care Medicine

Best Publications

  • Epidemiology and Outcomes of Health-care–Associated Pneumonia: Results From a Large US Database of Culture-Positive Pneumonia

    Marin H. Kollef;Andrew Shorr;Ying P. Tabak;Vikas Gupta

  • Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis

    Christopher J. Lettieri;Steven D. Nathan;Scott D. Barnett;Shahzad Ahmad

  • Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

    Richard G. Wunderink;Michael S. Niederman;Marin H. Kollef;Andrew F. Shorr

  • Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations.

    Derek C. Angus;Andrew F. Shorr;Alan White;Tony T. Dremsizov

  • Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005.

    Marya D. Zilberberg;Andrew F. Shorr;Marin H. Kollef

  • Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

    Richard G. Wunderink;Yuko Matsunaga;Mari Ariyasu;Philippe Clevenbergh

  • Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant

    A F Shorr;J L Wainright;C S Cors;C J Lettieri

  • Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database.

    Andrew F. Shorr;Ying P. Tabak;Aaron D. Killian;Vikas Gupta

  • Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study

    Marya D Zilberberg;Andrew F Shorr;Scott T Micek;Cristina Vazquez-Guillamet

  • Dynamic evolution of coagulopathy in the first day of severe sepsis : Relationship with mortality and organ failure

    Jean-Francois Dhainaut;Andrew F. Shorr;William L. Macias;Marin J. Kollef

  • Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

    Ethan Rubinstein;Tahaniyat Lalani;G. Ralph Corey;Zeina A. Kanafani

  • Economic implications of an evidence-based sepsis protocol: Can we improve outcomes and lower costs?*

    Andrew F. Shorr;Scott T. Micek;William L. Jackson;Marin H. Kollef

  • Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia.

    Andrew F. Shorr;Marya D. Zilberberg;Scott T. Micek;Marin H. Kollef

  • Red blood cell transfusion and ventilator-associated pneumonia: A potential link?

    Andrew F. Shorr;Mei-Sheng Duh;Kathleen M. Kelly;Marin H. Kollef

  • Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies

    Andrew F. Shorr;Mark J. Kunkel;Marin Kollef

  • Ventilator-Associated Pneumonia: The Clinical Pulmonary Infection Score as a Surrogate for Diagnostics and Outcome

    Marya D. Zilberberg;Andrew F. Shorr

  • A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

    Matteo Bassetti;Monia Marchetti;Arunaloke Chakrabarti;Sergio Colizza

  • Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis

    Andrew F. Shorr;John H. Sherner;William L. Jackson;Marin H. Kollef

  • Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit.

    Andrew F. Shorr

  • Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis.

    Andrew F. Shorr;Kevin Chung;William L. Jackson;Paige E. Waterman

Frequent Co-Authors

Marin H. Kollef
Marin H. Kollef Washington University in St. Louis
Jeffrey Lipman
Jeffrey Lipman University of Queensland
Michael S. Niederman
Michael S. Niederman Cornell University
Daren K. Heyland
Daren K. Heyland Queen's University
Matteo Bassetti
Matteo Bassetti University of Genoa
Vikas Gupta
Vikas Gupta Princess Margaret Cancer Centre
Richard G. Wunderink
Richard G. Wunderink Northwestern University
G. Ralph Corey
G. Ralph Corey Duke University
Jason A. Roberts
Jason A. Roberts University of Queensland
Jean-François Timsit
Jean-François Timsit Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare careers beyond becoming a doctor, several online degree options can offer flexible and affordable pathways. Fields like health information management remain in high demand, and there are accredited HIM programs that allow students to study remotely while preparing for vital data and compliance roles in medical settings.

Many are also considering the average cost of medical billing and coding program options, which make it possible to enter the workforce quickly without a four-year degree. These programs deliver core skills for managing insurance claims and patient records.

For those interested in direct patient care, the cheapest online acute care nurse practitioner programs and other affordable online nursing programs enable students to advance their nursing education at a lower cost. These degrees open doors to specialized roles, higher pay, and greater autonomy.

Whichever path you choose, these online healthcare degrees can help launch or advance your career, often with more flexibility and lower expenses than traditional programs.

Best Scientists Citing Andrew F. Shorr

Trending Scientists

Recently Published Articles